Generation Bio Co (GBIO NASDAQ) stock market data APIs
$5.5899
0.42(7.5%)
as of September 15, 2025
Try our APIs with
free plan!
Generation Bio Co Financial Data Overview
Price chart is built with
Anychart
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Prev. Close
5.5899
Open
6.0073
High
5.9959
Low
5.5587
52 wk Range
3-29.1
Market Cap
39 942 K
Shares Outstanding
6 736 K
Revenue
21 230 K
EPS
-1.56
Beta
2.486
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Generation Bio Co (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Generation Bio Co data using free add-ons & libraries
Get Generation Bio Co Fundamental Data
Generation Bio Co Fundamental data includes:
- Net Revenue: 21 230 K
- EBITDA: -70 321 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.2783
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Generation Bio Co News
New
Generation Bio’s SWOT analysis: ctLNP tech stock faces pivotal moment
Generation Bio Co. (NASDAQ:GBIO), a biotechnology company specializing in siRNA and CAR-T capabilities with a market capitalization of $42.4 million, finds itself at a critical juncture as it navigate...
Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Today, a brief rundown of news involving Precigen and...
Sector Update: Health Care Stocks Climb Late Afternoon
Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index and the Health Car PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Here are the top movers in Wednesday's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT MNTS [https://www.chartmill.com/s...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
